INMD
Undervalued by 77.5% based on the discounted cash flow analysis.
Market cap | $1.57 Billion |
---|---|
Enterprise Value | $794.89 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $2.1 |
Beta | 1.93 |
Outstanding Shares | 83,982,462 |
Avg 30 Day Volume | 1,264,863 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 8.64 |
---|---|
PEG | -20.83 |
Price to Sales | 3.69 |
Price to Book Ratio | 2.05 |
Enterprise Value to Revenue | 1.7 |
Enterprise Value to EBIT | 4.6 |
Enterprise Value to Net Income | 4 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...